Cite
HARVARD Citation
Kuhn, P. et al. (2017). Lessons Learned: Transfer of the High‐Definition Circulating Tumor Cell Assay Platform to Development as a Commercialized Clinical Assay Platform. Clinical pharmacology & therapeutics. 102 (5), pp. 777-785. [Online].